Vamsi Reddy

Vamsi Reddy: Global MedTech Executive, Top 1% Biomedical Innovator, R&D/Product Strategist, Pioneer of Connected System

  • $0M+

    Capital Deployed

  • 0+

    Global Product Lines

  • 0+

    Patents

Translational Neuroengineering PioneerTop 1% Systems InnovatorGlobal Life Sciences Technical AdjudicatorCross-Continental R&D LeaderExpert Peer ReviewerGlobal Commercialization StrategistNew Product Innovation (NPI) ExpertNIH Principal InvestigatorGlobal QMS StrategistGlobal Keynote SpeakerPublic Speaker

Speaking & Appearances

Commanding the Global Stage.

A globally broadcast technology leader reaching millions, Vamsi Reddy commands international keynotes, elite industry summits, and major media platforms to architect the commercial future of worldwide medical technology.

Inquire for Keynote & Advisory
5
Jul 2026Reflection

The Power of 5

5 Years at Evon Medics, Inc.

A milestone reflection framed around five: five roles held, five NIH SBIR grants led across NIA/NIDA/NINDS ($12M+ non-dilutive), five patents authored, and five immigration milestones through EB-1A.

Read on LinkedIn
May 2026Showcase

COAT™ and MemoryDriver™ at the Amplify MedTech Startup Showcase

Amplify MedTech · DMV region, USA

Pitched Evon Medics' COAT™ brain-atrophy therapeutic and MemoryDriver™ digital therapeutic to the DMV-area MedTech community.

Apr 2026Summit

Building Global Health Technology Products

HealthX Africa

A master class on product definition, MVP scoping and regulatory rigor — drawing on Evon Medics' path to building globally scalable digital health products for international markets.

Oct 2025Guest lecture

Labs to Launch: What Really Matters in MedTech

Johns Hopkins University — Biomedical Engineering · Baltimore, MD

Invited by Dr. Nitish V. Thakor to lecture the BME community on translating biomedical engineering from the laboratory bench to real-world, market-ready products.

Jul 2025Reflection

Four Years at Evon Medics

LinkedIn reflection

Leading global product development across software, hardware, mechanical, electrical and embedded engineering; PI / Co-I / Lead Product Engineer on NIH-funded projects; $12M+ non-dilutive NIH funding secured since 2021; multiple patents filed.

Read on LinkedIn
Apr 2023Conference

ASAM 54th Annual Conference

American Society of Addiction Medicine · Washington, D.C.

Represented Evon Medics at ASAM's annual conference, engaging addiction-medicine specialists, researchers and healthcare leaders on innovations in addiction medicine and science.

Mar 2023Conference

Governor's Institute Addiction Medicine Conference

Governor's Institute · Asheville, NC

Engaged healthcare professionals, researchers and policymakers on emerging approaches to substance-use-disorder treatment and Evon Medics' digital therapeutic technologies.

Oct 2022Summit

American Medical Device Summit 2022

Generis Group · Chicago, IL

Reflections on the summit floor — presentations, global-strategy discussions, and one-on-one meetings with industry leaders and company delegates.

Read on LinkedIn
Jul 2022Guest lecture

Biomedical Engineering Prospects in the USA

Melody Mocktail — career guidance session

A career-guidance conversation on biomedical engineering pathways in the United States, broadcast to a combined audience of more than two million followers across YouTube and Instagram.

Watch on YouTube
Aug 2021Guest lecture

Biomedical Engineering Beyond India

NIT Rourkela — Dept. of Biotechnology & Medical Engineering

An invited talk for the Department of Biotechnology and Medical Engineering on building a biomedical engineering career beyond India.

Watch on YouTube

NIH-Funded Innovation

Peer-Reviewed
Impact.

Peer-reviewed NIH SBIR programs and a patented digital therapeutic, each taken from grant application through clinical validation and toward market.

NIH / NIA

Clinical Phase II

EMRAST

Early Multi-Modal Alzheimer's Risk Assessment & Sensing Technology

Multimodal diagnostic platform combining psychophysical olfactory stimulation with ML-based biomarker classification for pre-clinical Alzheimer's detection. Randomized feasibility trial published in Alzheimer's & Dementia.

Role
Principal Investigator
Funding
$2.95M
Grant
R44AG082621
Status
Clinical Validation
  • Phase I · 2023$449K
  • Phase II · 2024$1.25M
  • Phase II · 2025$1.25M

Alzheimer's & Dementia: TR&CI · Randomized feasibility clinical trial (Article TRC270226)

BioelectronicsMachine LearningFDA 21 CFR 820ISO 13485

NIH / NIDA

Phase II Active

EDITOR

Early Detection & Intervention Tool for Opioid Recovery

Connected RPM ecosystem with a novel non-infrared pupillometer enabling objective neurological assessment for opioid use disorder monitoring and MAT efficacy evaluation.

Role
Co-Investigator
Funding
$2.70M
Grant
R44DA056156
Status
Active Development
  • Phase I · 2022$331K
  • I-CORPS · 2023$55K
  • Phase II · 2023$1.32M
  • Phase II · 2023$1.00M

USPTO 63/774,619 · Pupillometer and Related Methods — Co-Inventor, filed March 2025

OptoelectronicsEdge AIBLE 5.0AWS IoT

Internal R&D (Non-NIH)

Market Ready

MemoryDriver

AI-Powered Digital Therapeutic for Cognitive Longevity

Patented iOS digital therapeutic combining AI-driven cognitive assessments with personalized brain training. HIPAA-compliant, AWS-hosted, with longitudinal performance tracking — built 0-to-1 as a commercial product.

Role
Product Lead & Inventor
Funding
Commercial
Type
DTx
Status
Market Ready

USPTO 63/783,072 · Memory Impairment Classifier Apparatus — Co-Inventor, filed April 2025

iOS DevelopmentMachine LearningAWS ArchitectureHIPAA Compliance

Let's build what's next

Let's Talk.

Whether you're scaling a MedTech venture, navigating regulatory pathways, or assembling a world-class R&D team, let's talk about what we build next.

Request a Briefing